Related content

Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication

By Rossi Marco   Magagna Armando   Di Maria Cinzia   Franzoni Ferdinando   Taddei Stefano   Santoro Gino  

Blood Pressure, Vol. 17, Iss. 1, 2008-01 ,pp. : 18-25

Informa Healthcare

Access to resources Recommend Favorite

The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis

By Pauling J. D.   O’Donnell V. B.   Mchugh N. J.  

Platelets, Vol. 24, Iss. 7, 2013-11 ,pp. : 503-515

Informa Healthcare

Access to resources Recommend Favorite

Autophagy is a key feature in the pathogenesis of systemic sclerosis

By Frech Tracy   Domenico Ivana   Murtaugh Maureen   Revelo Monica   Li Dean   Sawitzke Allen   Drakos Stavros  

Rheumatology International, Vol. 34, Iss. 3, 2014-03 ,pp. : 435-439

Springer Publishing Company

Access to resources Recommend Favorite

Systemic Sclerosis: From Pathogenesis Towards Targeted Immunotherapies

By  

Current Rheumatology Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 45-55

Bentham Science Publishers

Access to resources Recommend Favorite

Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 2, 2008-04 ,pp. : 80-91

Bentham Science Publishers

Access to resources Recommend Favorite